88 related articles for article (PubMed ID: 16611285)
1. Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study.
Di Mario F; Aragona G; Dal Bó N; Cavallaro L; Marcon V; Olivieri P; Benedetti E; Orzès N; Marin R; Tafner G; Chilovi F; De Bastiani R; Fedrizzi F; Franceschi M; Salvat MH; Monica F; Piazzi L; Valiante F; Vecchiati U; Cavestro GM; Comparato G; Iori V; Maino M; Leandro G; Pilotto A; Rugge M; Franzè A;
Aliment Pharmacol Ther; 2006 Apr; 23(8):1235-40. PubMed ID: 16611285
[TBL] [Abstract][Full Text] [Related]
2. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study.
Zullo A; De Francesco V; Scaccianoce G; Hassan C; Panarese A; Piglionica D; Panella C; Morini S; Ierardi E
Dig Liver Dis; 2005 Jul; 37(7):496-500. PubMed ID: 15975536
[TBL] [Abstract][Full Text] [Related]
3. Effect of lactoferrin supplementation on the effectiveness and tolerability of a 7-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection.
Tursi A; Elisei W; Brandimarte G; Giorgetti GM; Modeo ME; Aiello F
Med Sci Monit; 2007 Apr; 13(4):CR187-90. PubMed ID: 17392649
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics.
de Bortoli N; Leonardi G; Ciancia E; Merlo A; Bellini M; Costa F; Mumolo MG; Ricchiuti A; Cristiani F; Santi S; Rossi M; Marchi S
Am J Gastroenterol; 2007 May; 102(5):951-6. PubMed ID: 17313499
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study.
Zullo A; De Francesco V; Scaccianoce G; Manes G; Efrati C; Hassan C; Maconi G; Piglionica D; Cannaviello C; Panella C; Morini S; Ierardi E
Dig Liver Dis; 2007 Sep; 39(9):806-10. PubMed ID: 17644057
[TBL] [Abstract][Full Text] [Related]
6. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
Nista EC; Candelli M; Zocco MA; Cremonini F; Ojetti V; Finizio R; Spada C; Cammarota G; Gasbarrini G; Gasbarrini A
Am J Gastroenterol; 2006 Sep; 101(9):1985-90. PubMed ID: 16968503
[TBL] [Abstract][Full Text] [Related]
7. Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong?
Hung IF; Chan P; Leung S; Chan FS; Hsu A; But D; Seto WK; Wong SY; Chan CK; Gu Q; Tong TS; Cheung TK; Chu KM; Wong BC
Helicobacter; 2009 Dec; 14(6):505-11. PubMed ID: 19889067
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication.
Tursi A; Cammarota G; Montalto M; Papa A; Cuoco L; Veneto GM; Cannizzaro O; Fedeli G; Gasbarrini G
Panminerva Med; 1996 Sep; 38(3):145-9. PubMed ID: 9009677
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori infection: a randomized prospective study.
Zullo A; Rinaldi V; Pugliano F; Diana F; Attili AF
Am J Gastroenterol; 1997 Nov; 92(11):2029-31. PubMed ID: 9362185
[TBL] [Abstract][Full Text] [Related]
10. Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication.
Di Caro S; Franceschi F; Mariani A; Thompson F; Raimondo D; Masci E; Testoni A; La Rocca E; Gasbarrini A
Dig Liver Dis; 2009 Jul; 41(7):480-5. PubMed ID: 18974025
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
Zheng Q; Pan Y; Zhang L; Xiao SD
Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
[TBL] [Abstract][Full Text] [Related]
12. Use of bovine lactoferrin for Helicobacter pylori eradication.
Di Mario F; Aragona G; Dal Bò N; Cavestro GM; Cavallaro L; Iori V; Comparato G; Leandro G; Pilotto A; Franzè A
Dig Liver Dis; 2003 Oct; 35(10):706-10. PubMed ID: 14620619
[TBL] [Abstract][Full Text] [Related]
13. Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection.
Nista EC; Candelli M; Zocco MA; Cazzato IA; Cremonini F; Ojetti V; Santoro M; Finizio R; Pignataro G; Cammarota G; Gasbarrini G; Gasbarrini A
Aliment Pharmacol Ther; 2005 May; 21(10):1241-7. PubMed ID: 15882245
[TBL] [Abstract][Full Text] [Related]
14. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
[TBL] [Abstract][Full Text] [Related]
16. A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection.
Trevisani L; Sartori S; Caselli M; Ruina M; Verdianelli G; Abbasciano V
Am J Gastroenterol; 1998 Mar; 93(3):390-3. PubMed ID: 9517646
[TBL] [Abstract][Full Text] [Related]
17. Six-day therapy with ranitidine bismuth citrate plus low-dose clarithromycin and tinidazole to cure Helicobacter pylori infection.
Cammarota G; Cannizzaro O; Cianci R; Gasbarrini A; Pirozzi G; Gasbarrini G
Hepatogastroenterology; 2000; 47(34):1176-9. PubMed ID: 11020908
[TBL] [Abstract][Full Text] [Related]
18. Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy.
Kang JM; Kim N; Lee DH; Park YS; Kim YR; Kim JS; Jung HC; Song IS
Helicobacter; 2007 Dec; 12(6):623-8. PubMed ID: 18001404
[TBL] [Abstract][Full Text] [Related]
19. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.
Marzio L; Coraggio D; Capodicasa S; Grossi L; Cappello G
Helicobacter; 2006 Aug; 11(4):237-42. PubMed ID: 16882326
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a four-drug, three-antibiotic, nonbismuth-containing "concomitant" therapy as first-line Helicobacter pylori eradication regimen in Greece.
Georgopoulos S; Papastergiou V; Xirouchakis E; Laudi F; Papantoniou N; Lisgos P; Spiliadi C; Fragou P; Skorda L; Karatapanis S
Helicobacter; 2012 Feb; 17(1):49-53. PubMed ID: 22221616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]